Cargando…

Molecular imaging biomarkers for immune checkpoint inhibitor therapy

Immune checkpoint inhibitors (ICIs) have substantially changed the field of oncology over the past few years. ICIs offer an alternative treatment strategy by exploiting the patients' immune system, resulting in a T cell mediated anti-tumor response. These therapies are effective in multiple dif...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Donk, Pim P, Kist de Ruijter, Laura, Lub-de Hooge, Marjolijn N, Brouwers, Adrienne H, van der Wekken, Anthonie J, Oosting, Sjoukje F, Fehrmann, Rudolf SN, de Groot, Derk Jan A, de Vries, Elisabeth GE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993216/ https://www.ncbi.nlm.nih.gov/pubmed/32042331 http://dx.doi.org/10.7150/thno.38339

Ejemplares similares

Molecular imaging to support cancer immunotherapy
por: van de Donk, Pim P, et al.
Publicado: (2022)

Whole-body CD8(+) T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
por: Kist de Ruijter, Laura, et al.
Publicado: (2022)

Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
por: van Sluis, Joyce, et al.
Publicado: (2022)

Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape
por: Oosting, Sjoukje F, et al.
Publicado: (2017)

Comparative biodistribution analysis across four different (89)Zr-monoclonal antibody tracers—The first step towards an imaging warehouse
por: Bensch, Frederike, et al.
Publicado: (2018)

Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine
por: Pool, Martin, et al.
Publicado: (2017)

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types
por: Lamberts, Laetitia E., et al.
Publicado: (2015)

Optimisation of scan duration and image quality in oncological (89)Zr immunoPET imaging using the Biograph Vision PET/CT
por: van Sluis, Joyce, et al.
Publicado: (2023)

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
por: Boonstra, Pieter A., et al.
Publicado: (2020)

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer (89)Zr-imgatuzumab
por: Pool, Martin, et al.
Publicado: (2016)

(89)Zr-mAb3481 PET for HER3 tumor status assessment during lapatinib treatment
por: Pool, Martin, et al.
Publicado: (2017)

(89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics
por: Pool, Martin, et al.
Publicado: (2017)

Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice
por: Waaijer, Stijn J. H., et al.
Publicado: (2021)

(89)Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
por: van der Veen, Elly L, et al.
Publicado: (2020)

Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate
por: Waaijer, Stijn JH, et al.
Publicado: (2020)

(89)Zr-PET imaging to predict tumor uptake of (177)Lu-NNV003 anti-CD37 radioimmunotherapy in mouse models of B cell lymphoma
por: Giesen, Danique, et al.
Publicado: (2022)

MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
por: Stutvoet, Thijs S, et al.
Publicado: (2019)

Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers
por: Peters, Marloes A. M., et al.
Publicado: (2019)

Pharmacokinetic Boosting of Kinase Inhibitors
por: Westra, Niels, et al.
Publicado: (2023)

(89)Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
por: Bensch, Frederike, et al.
Publicado: (2018)

Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
por: Rossi, Niccolò, et al.
Publicado: (2022)

Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with (89)Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts
por: ter Weele, Eva J., et al.
Publicado: (2015)

Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
por: Hartmans, Elmire, et al.
Publicado: (2017)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
por: Arjaans, Marlous, et al.
Publicado: (2016)

Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
por: van de Donk, Pim P., et al.
Publicado: (2021)

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2022)

Modelling Tools to Characterize Acetaminophen Pharmacokinetics in the Pregnant Population
por: Brookhuis, Sofie A. M., et al.
Publicado: (2021)

Clinical-grade N-(4-[(18)F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans
por: van der Veen, Elly L., et al.
Publicado: (2019)

The Effect of Pregnancy and Inflammatory Bowel Disease on the Pharmacokinetics of Drugs Related to Inflammatory Bowel Disease—A Systematic Literature Review
por: Wiersma, Thomas K., et al.
Publicado: (2022)

Regulators of homologous recombination repair as novel targets for cancer treatment
por: Krajewska, Małgorzata, et al.
Publicado: (2015)

Molecular imaging: what can be used today: Monday 3 October 2005, 11:15–12:00
por: Jager, P L, et al.
Publicado: (2005)

Driving innovation for rare skin cancers: utilizing common tumours and machine learning to predict immune checkpoint inhibitor response
por: Hooiveld-Noeken, J.S., et al.
Publicado: (2019)

PET/CT Imaging of (89)Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys
por: Li, Wenping, et al.
Publicado: (2020)

Pancreatic cyst development: insights from von Hippel-Lindau disease
por: van Asselt, Sophie J, et al.
Publicado: (2013)

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage
por: Altena, Renske, et al.
Publicado: (2015)

Comparison of [(18)F]DOPA and [(68)Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
por: Veenstra, Emile B., et al.
Publicado: (2022)

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
por: Lee, Karla A., et al.
Publicado: (2022)

Transcriptional effects of copy number alterations in a large set of human cancers
por: Bhattacharya, Arkajyoti, et al.
Publicado: (2020)

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
por: Oosting, Sjoukje F., et al.
Publicado: (2019)

Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review
por: Appeldoorn, T. Y. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cso0rt3bs19b3n16418v1ubjdm